查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球神经假体市场-2022-2029
市场调查报告书
商品编码
1140760

全球神经假体市场-2022-2029

Global Neuroprosthetics Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

预计神经假体的市场规模在预测期间（2022-2029 年）将以 12.2% 的复合年增长率增长。

神经假体是神经科学和生物医学工程的一个分支，涉及神经假体的开发。这些是一系列可以替代因受伤或疾病而受损的运动、感觉、认知和其他功能的设备。

市场动态

全球神经假体市场正在增长，这得益于多种因素，例如患有神经系统疾病和损伤的患者人数增加、糖尿病患病率增加、听力损失发生率增加以及设备技术进步。

神经假体的不断进步和对神经假体的日益增长的需求正在推动全球市场的增长。

神经假体的进步和发展正在推动市场的增长。例如，ABBOT 的 DRG（背根神经节）疗法有助于治疗 I 型和 II 型复杂区域疼痛综合征 (CRPS) 成人患者下肢严重慢性顽固性疼痛以及人工关节相关的慢性疼痛。或两者兼而有之，这种疗法使用温和的电信号来治疗慢性疼痛。而由 Neurospace, Inc. 开发的 RNS 系统是唯一获得 FDA 批准的癫痫治疗设备，它可以响应异常的大脑活动并跟踪 EEG 数据以提供个性化的治疗和患者护理。它帮助我改进。此外，波士顿科学公司还推出了 Vercise DBS，这是一种具有精确神经靶向的神经假体，可以为帕金森病、原发性和继发性肌张力障碍、特发性震颤患者提供个性化治疗，也是该设备的最早开发公司。此外，创伤性脑损伤和神经系统疾病的增加正在推动全球市场的增长。例如，在过去 30 年中，大约有三分之一的人会在其生命的某个阶段患有神经系统疾病，而死于神经系统疾病的人数增加了近 40%。每年大约有 20 到 5000 万人因交通事故而遭受非致命伤害，据说其中大多数人患有某种神经系统疾病。

此外，每年约有 20 到 5000 万人因道路交通事故而遭受非致命伤害，其中大多数人患有某种形式的神经损伤。

但是，设备的高成本阻碍了市场增长。神经假体是一种新兴的听力障碍治疗选择，这使得它们非常昂贵，尤其是在发展中国家。人工耳蜗、视觉和海马（或认知）等神经假体通常非常昂贵，因此大多数患者无法使用。

行业分析

全球神经假体市场报告基于波特五力、创新、新产品发布和定价等各种行业因素对市场进行了深入分析。

COVID-19 影响分析

在 COVID-19 期间，由于供应链中断、市场上原材料稀缺以及大多数研究机构和大学关闭，全球研发项目被搁置。此外，大流行期间常规医疗保健检查的困难以及旅行和社交的限制使大多数患有神经系统疾病的患者未被发现。

细分分析

在预测期内（2022-2029 年），输出型神经假体有望主导全球市场。

输出神经假体包括认知假体和人工耳蜗。输出型神经假体将在 2021 年占据最大的市场份额。输入神经假体包括仿生眼/视网膜植入物。由于渗透率的提高和产品创新研发力度的加大，预计视网膜植入物在预测期内将以最快的速度增长。例如，对于人工耳蜗，每年要花费数百万美元来实现更强大、更有效的听力治疗方案。例如，在人工耳蜗的情况下，已经努力通过电极设计更好地保护内耳的神经结构，并通过佩戴在双耳上的设备联网提供更自然的听觉体验。此外，我们正致力于通过利用人工智能和引入新的信号处理算法来改善听觉体验，并开发使用应用程序的远程控制。

区域分析

据估计，北美将主导全球神经假体市场。

由于脑外伤发病率高、老年人口不断增加以及研发投资增加，北美地区拥有世界神经假体的主要部分。例如，根据疾病预防控制中心的数据，2020 年约有 64,362 人死亡，其中每天有 611 人因脑外伤而住院和 176 人死亡。 CDC 提供的这些统计数据不包括急诊科、初级保健、紧急护理或未经治疗的创伤性脑损伤。 75 岁及以上的患者在创伤性脑损伤中的数量和发生率最高。因此，北美日益增长的老年人口也是使北美主导全球市场的一个因素。例如，根据人口事务研究所的统计数据，从人口普查局 2020 年的人口中推断，超过 5500 万美国人年龄在 65 岁及以上。此外，研发投资的增加、政府和私人机构的资金增加以及神经植入物製造商的大量存在正在推动该地区的市场增长。例如，美国国防高级研究计划局 (DARPA) 和美国国家神经疾病和中风研究所 (NIH) 正在与联邦机构合作，提供资金来支持研发计划，以进一步开发神经植入物。

竞争格局

神经假体市场竞争激烈，少数主要参与者争夺市场份额。全球神经假体市场的主要参与者包括波士顿科学、美敦力、雅培、Cochlear、LivaNova、Sonova、Retina Implant、Med-El、Neuropace 和 NDI Medical 等。主要参与者采取了各种增长战略，如产品发布、併购、合作伙伴和合作，为全球神经假体市场的增长做出了贡献。例如，2022 年 8 月 31 日，美敦力与 BioIntelliSense 合作，获得了多参数可穿戴设备的美国独家商业权利，用于从医院到家庭的连续远程患者监测。此外，2022 年 8 月 30 日，美敦力收购了 Afera。

概述：

Medtronic PLC 是一家总部位于爱尔兰的美国医疗设备製造商。美敦力公司成立于 1949 年，总部位于美国明尼苏达州明尼阿波利斯市。美敦力经营四项业务：微创治疗组、糖尿病组、恢復性治疗组和心血管组。

产品组合

Medtronic plc 的神经修復产品组合包括 Percept PC DBS 系统、Activa RC 系统、SenSight Directional Leads、VANTA PC Neurostimulator、INTELLIS Neurostimulator、Primeadvanced Surescan MRI Neurostimulator 和 Restore。

全球神经假体市场报告将提供对大约 40 多个市场数据表、45 多个图表和 200 多个页面（大约）的访问。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 创新与发展
      • 对神经假体的需求不断增长
    • 限制因素
      • 高成本
      • 缺乏熟练的专业人员
    • 商机
    • 影响分析

第5章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 输出神经假体
    • 机车假肢
    • 认知功能假体
  • 输入神经假体
    • 人工耳蜗
    • 人工耳蜗/视网膜植入物

第 8 章技术

  • 脊髓刺激疗法
  • 深层脑刺激疗法
  • 迷走神经刺激
  • 经颅磁刺激
  • □神经刺激
  • 其他

第 9 章。按应用程序

  • 生理障碍
    • 听觉信息处理障碍
    • 眼科疾病
    • 循环区
    • 泌尿科
  • 运动神经元疾病
    • 帕金森病
    • 癫痫
  • 认知障碍专业化
    • 阿尔茨海默氏症
    • 瘫痪

第 10 章，最终用户

  • 医院
  • 专门的神经外科设施
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准

第 13 章公司简介

  • 美敦力公司
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Boston Scientific
  • Abbott
  • Cochlear
  • LivaNova
  • Sonova
  • Retina Implant
  • Med-El
  • Neuropace
  • NDI Medical

第14章 DataM

简介目录
Product Code: DMMD2173

Market Overview

Neuroprosthetics Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 12.2% during the forecast period (2022-2029).

Neuroprosthetics (neural prosthetics) is a branch of neuroscience and biomedical engineering concerned with developing neural prostheses. These are a series of devices that can substitute for the functions of a motor, sensory, or cognitive modality that may have been damaged because of an injury or a disease.

Market Dynamics

The global neuroprosthetics market is growing due to several factors, such as the rising number of patients suffering from neurological disorders and nerve injuries, the growing prevalence of diabetes, the increasing incidence of hearing loss, and technological advancements in the devices.

The rising advancements in neuroprosthetics and the growing need for neuroprosthetics are fueling global market growth.

The advancements and developments in neuroprosthetics are fueling market growth. For instance, DRG (Dorsal Root Ganglion) therapy by ABBOT helps in treating chronic pain associated with severe chronic intractable pain of the lower limbs in adult patients with complex regional pain syndrome (CRPS) types I and II post-amputation or both prosthetic implant; this therapy acts by using mild electrical signals to treat chronic pain. Furthermore, the RNS system developed by Neurospace is the only FDA-approved epilepsy device that provides personalized treatment by responding to abnormal brain activity and tracking EEG data which helps in improving patient care. Moreover, Boston Scientific is the first to engineer a neuroprosthetic called Vercise DBS for accurate neural targeting allowing personalized therapy for patients with Parkinson's disease, primary and secondary dystonia, and essential tremor. In addition, the growing incidences of traumatic brain injuries and neurological diseases are fueling the global market growth; for instance, around 1 in 3 people have been affected by a neurological disease at some point in their life over the past 3 decades, and the neurological disorder deaths have increased by almost 40%; also, around 20-50 million people yearly suffer from non-fatal injuries road crashes majority of which suffer from some neurological damage.

The high cost will hamper the global market growth.

However, the high cost of the devices hinders the market's growth. Neuroprosthetics is an emerging treatment option for hearing damage, which makes them very expensive, especially in developing countries. Neuroprosthetics such as cochlear, visual, and hippocampal (or cognition) prostheses are generally very expensive and make it difficult for most patients to access.

Industry analysis.

The global neuroprosthetics market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, Etc.

COVID-19 Impact Analysis

The supply chain was disrupted during COVID-19, which caused a lack of raw materials in the market, putting global research and development projects on hold as most of the research institutes and universities were shut down. Moreover, regular healthcare check-ups were difficult amidst the pandemic, leaving most patients with undetected neurological disorders because of the travel and socializing restrictions; there was a reduction in road and traffic injuries reducing the cases of traumatic brain injury, and overall impacting the neuroprosthetics market.

Segment Analysis

The output neural prosthetics are predicted to dominate the global market during the forecast period (2022-2029).

The output neural prosthetics include cognitive prosthetics and cochlear implants. The output neural prosthetics accounted for the largest market share in 2021. The input neural prosthetics include bionic eye/retinal implants. Retinal implants are estimated to grow at the fastest growth rate during the forecast period, owing to the rising penetration and the increasing R&D efforts for product innovation. For instance, in the case of cochlear implants, millions of dollars are being spent every year to achieve even more powerful and effective hearing treatment options. These efforts include better preserving the neural structures in the inner ear through electrode design and bringing a more natural hearing experience through networking the devices worn on both ears. Furthermore, work on ways to improve the hearing experience through the argumentation of artificial intelligence and the introduction of new signal processing algorithms, as well as to develop app-based remote controls.

Geographical Analysis

North America is estimated to subjugate the global Neuroprosthetics market.

The North American region holds the major part of the global Neuroprosthetics Since there are high incidences of traumatic brain injuries, a growing geriatric population, and increasing R&D investments. For instance, according to the CDC data, around 64,362 deaths in 2020 were claimed by traumatic brain injury, making up 611 hospitalizations and 176 deaths daily to traumatic brain injury as the cause. These statistics CDC provided exclude the traumatic brain injuries treated in emergency departments, primary care, urgent care or untreated ones. Patients aged 75 and older were the ones that accounted for the highest number and rates of traumatic brain injuries. Therefore, the growing geriatric population in North America is also a contributing factor to North America's command over the global market. For instance, according to statistics from The Population Reference Bureau, over 55 million Americans are 65 or older, per the estimate from the Census Bureau's 2020 population. In addition, increasing R&D investments, growing funding from government and private institutes, and the large presence of neural implant manufacturers drive market growth in this region. For instance, the Defense Advanced Research Project Agency (DARPA) and National Institute of Neurological Disorders and Stroke (NIH), in collaboration with federal agencies, are instrumental in providing funds to support R&D initiatives for the further development of neural implants.

Competitive Landscape

The neuroprosthetics market is competitive, with few major players competing to gain market share. Some major players in the global neuroprosthetics market include Boston Scientific, Medtronic, Abbott, Cochlear, LivaNova, Sonova, Retina Implant, Med-El, Neuropace, and NDI Medical, among others. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations contributing to the growth of the neuroprosthetics market globally. For instance, AUG 31, 2022, Medtronic partnered with BioIntelliSense for exclusive U.S. distribution of multi-parameter wearables for continuous remote patient monitoring from in-hospital to home. Also, AUG 30, 2022, Medtronic acquired Affera.

Medtronic, Plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

Medtronic plc's product portfolio for neuroprosthetics has Percept PC DBS System, Activa RC system, SenSight Directional Leads, VANTA PC Neurostimulator, INTELLIS Neurostimulator, Primeadvanced Surescan MRI Neurostimulator, and Restore.

The global neuroprosthetics market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations and Developments
      • 4.1.1.2. The Growing Need For Neuroprosthetics
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost
      • 4.1.2.2. Lack of Skilled Professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Output Neural Prosthetics
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Motor Prosthetics
    • 7.2.4. Cognitive Prosthetics
  • 7.3. Input Neural Prosthetics
    • 7.3.1. Cochlear Implants
    • 7.3.2. BImplants/Retinal Implants

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
    • 8.1.2. Market Attractiveness Index, By Technology Segment
  • 8.2. Spinal Cord Stimulation
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Deep Brain Stimulation
  • 8.4. Vagus Nerve Stimulation
  • 8.5. Transcranial magnetic Stimulation
  • 8.6. Sacral Nerve Stimulation
  • 8.7. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Physiological Disorders
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 9.2.3. Auditory Processing Disorders
    • 9.2.4. Ophthalmic Disorders
    • 9.2.5. Cardiovascular Disorders
    • 9.2.6. Urology Disorder
  • 9.3. Motor Neuron Disorders
    • 9.3.1. Parkinson's Disease
    • 9.3.2. Epilepsy
  • 9.4. Cognitive Disorders Specialized
    • 9.4.1. Alzheimer's Disease
    • 9.4.2. Paralysis

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Specialized Neurosurgery Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Medtronic Plc
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Boston Scientific
  • 13.3. Abbott
  • 13.4. Cochlear
  • 13.5. LivaNova
  • 13.6. Sonova
  • 13.7. Retina Implant
  • 13.8. Med-El
  • 13.9. Neuropace
  • 13.10. NDI Medical

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us